Firms/companies
Nestle close to buying Pfizer’s infant nutrition business for $9 billion
18 Apr 2012
Pfizer acquired the infant-nutrition division in its $68-billion takeover of Wyeth in 2009, and since early July 2011, has been planning to divst it and focus on its core biopharmaceutical products
Nestle close to buying Pfizer’s infant nutrition business for $9 billion
18 Apr 2012
Pfizer acquired the infant-nutrition division in its $68-billion takeover of Wyeth in 2009, and since early July 2011, has been planning to divst it and focus on its core biopharmaceutical products
Nestle close to buying Pfizer’s infant nutrition business for $9 billion
18 Apr 2012
Pfizer acquired the infant-nutrition division in its $68-billion takeover of Wyeth in 2009, and since early July 2011, has been planning to divst it and focus on its core biopharmaceutical products
New tax law: Vodafone threatens arbitration against government
17 Apr 2012
In its notice to the government, Vodafone said it would invoke the provisions of the bilateral investment treaty between India and the Netherlands
Essel Group has no plans to hike stake in IVRCL
17 Apr 2012
Essel Group has no plans to hike stake in IVRCL
17 Apr 2012
Piramal Healthcare buys Bayer’s molecular imaging and research portfolio
16 Apr 2012
The acquisition includes Florbetaben, a drug candidate for diagnosis of Alzheimer’s disease that is in the final stages of clinical trials, with potential to generate annual revenues of $1.5 billion
Piramal Healthcare buys Bayer’s molecular imaging and research portfolio
16 Apr 2012
The acquisition includes Florbetaben, a drug candidate for diagnosis of Alzheimer’s disease that is in the final stages of clinical trials, with potential to generate annual revenues of $1.5 billion
Piramal Healthcare buys Bayer’s molecular imaging and research portfolio
16 Apr 2012
The acquisition includes Florbetaben, a drug candidate for diagnosis of Alzheimer’s disease that is in the final stages of clinical trials, with potential to generate annual revenues of $1.5 billion
Latest articles
Featured articles
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
